Radical Cystectomy, Nutrition and Convalescence
- Conditions
- Urinary Bladder NeoplasmsBladder CancerCystectomy
- Interventions
- Dietary Supplement: Parenteral nutrition. SMOFKABIVEN infusion in central vene. Fresenius Kabi
- Registration Number
- NCT02238886
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The purpose of this study is to determine whether a goal directed nutritional intervention can reduce the convalescence period for patients undergoing radical cystectomy (RC).
The aim is to examine the effect on quality of life of a standard nutritional strategy of resting the bowel till clear signs of bowel recovery and feeding orally after bowel recovery versus a goal-directed nutritional intervention combining oral intake and parenteral nutrition, in patients undergoing RC.
- Detailed Description
The study is a randomized controlled trial. Inclusion criteria: Bladder cancer, ability to give an informed consent. Exclusion criteria: Previous radiation therapy at the pelvic area, ureterocutaneostomy or robot-assisted surgery. The intervention aims to secure that 75% of the patient's total energy and protein needs are met during hospitalization.
Primary outcome: Quality of Life, using the EORTC QLQ-C30 and BLM30 questionnaire. Secondary outcomes: Body-weight, Hand Grip strength, biochemical measures, length of hospital stay, time to bowel recovery. The follow-up period is 12 weeks. Statistical analysis is performed in collaboration with a statistician.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
- Bladder cancer
- Ability to give an informed consent
- Previous radiation therapy at the pelvic area
- Ureterocutaneostomy
- Robot-assisted surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Parenteral nutrition Parenteral nutrition. SMOFKABIVEN infusion in central vene. Fresenius Kabi Patients receives a goal-directed nutritional intervention combining oral intake and parenteral nutrition
- Primary Outcome Measures
Name Time Method Health related quality of life (HRQoL) using the EORTC QLQ-C30 and BLM30 (one combined questionnaire) meassured pre-operatively + 6 and 12 weeks following surgery Change from baseline HRQoL at 6 and 12 weeks following surgery
- Secondary Outcome Measures
Name Time Method length of hospital stay 12 week follow-up Time to bowel recovery 12 week follow-up Body weight preoperatively, 6 and 12 weeks postop Change from baseline weight at 6 and 12 weeks following the date of surgery
hand grip strength pre-operatively, 6 days and 6 weeks postop Change from baseline hand grip strength at 6 days and 6 weeks following the date of surgery
Trial Locations
- Locations (1)
Dep. of Urology. University Hospital Rigshospitalet, Copenhagen Denmark
🇩🇰Copenhagen, Denmark